Overview
Precision Instruments

MEDIKIT CO.,LTD.

Medikit Co., Ltd. is a medical device company specializing in the development, manufacturing, and sales of vascular and blood-related medical devices. Its core product lines include hemodialysis needles (indwelling needles for artificial dialysis), peripheral intravenous catheters for infusion and transfusion, and interventional products such as sheath introducers and angiographic catheters used in vascular imaging and endovascular treatment. The company sells these products to domestic and international healthcare providers, with manufacturing conducted primarily through its consolidated subsidiaries Togo Medikit Co., Ltd. and Medikit Vietnam Co., Ltd.

Market Cap
¥38.8B
US$246M
EV
¥17.4B
US$110M
Stock¥2,680▼-0.19%
US$1 = ¥157.45 (2026-10-26)
LTM EV/EBITDA
2.6
x
LTM EV/EBIT
3.9
x
LTM PER
12.4
x
LTM PBR
0.8
x
Stock vs TOPIX (1Y, base=100)vs TOPIX ▼-21.9%pt
1001
Oct 27, 25 – Oct 26, 26StockTOPIX
1Sep 11, 26VARECS Partners Limited changed stake (14.17%→14.53%)
MC → EV Bridge
38.8BUS$246MMarket Cap0.02BUS$0.11M+ Debt20.0BUS$127M− Cash1.43BUS$9.10M− Inv. Sec.17.4BUS$110MEV
AI Briefing
Generating insights…
Performance & Balance
Revenue 5Y (¥B)
20.1US$128M'22/321.6US$137M'23/321.9US$139M'24/322.6US$143M'25/323.8US$151M'26/3
EBITDA 5Y (¥B)
5.69US$36.2M'22/35.40US$34.3M'23/35.99US$38.1M'24/35.96US$37.8M'25/36.09US$38.7M'26/3
Net Income 5Y (¥B)
2.99US$19.0M'22/32.86US$18.2M'23/33.07US$19.5M'24/33.01US$19.1M'25/33.01US$19.1M'26/3
Capital Structure
100%
EquityD/E 0.00xDebt
Liquidity vs Debt 5Y (¥B)▲ Net Cash
CashInv. Sec.Debt
29.0US$184M'22/328.5US$181M'23/324.6US$156M'24/322.3US$142M'25/322.3US$141M0.02US$0.12M'26/3
Shareholders
Top 10 hold 81.8%
1
Nakajima Corporation Co., Ltd.
40.69%
2
GOLDMAN,SACHS & CO.REG (Standing Proxy: Goldman Sachs Japan Co., Ltd.)
9.68%
3
NORTHERN TRUST CO.(AVFC) RE FIDELITY FUNDS (Standing Proxy: The Hongkong and Shanghai Banking Corporation Limited, Tokyo Branch)
6.22%
4
GOLDMAN SACHS INTERNATIONAL (Standing Proxy: Goldman Sachs Japan Co., Ltd.)
6.16%
5
Nakajima Ikuei Scholarship Association (General Incorporated Foundation)
4.14%
6
Takashi NAKAJIMA
3.92%
7
Kazue KURITA
3.29%
8
NORTHERN TRUST CO.(AVFC) RE IEDU UCITS CLIENTS NON LENDING 15 PCT TREATY ACCOUNT (Standing Proxy: The Hongkong and Shanghai Banking Corporation Limited, Tokyo Branch)
3.28%
9
NORTHERN TRUST CO.(AVFC) RE NON TREATY CLIENTS ACCOUNT (Standing Proxy: The Hongkong and Shanghai Banking Corporation Limited, Tokyo Branch)
3.08%
10
MEDIKIT CO.,LTD. Employee Stock Ownership Association
1.30%
Management
9 officers
Yoji KAGEYAMA
Representative Director, President
May 1986 Joined the Company Apr 2007 Executive Officer, General Manager, East Japan Sales Division Apr 2008 Executive Officer, General Manager, Sales Division (in charge of West Japan) Jun 2009 Appointed Director Jun 2010 Appointed Managing Director Aug 2015 Managing Director, General Manager, Sales Division (in charge of East Japan), in charge of Overseas Business Division Apr 2020 Managing Director, General Manager, Sales Division (in charge of East Japan), in charge of Overseas Business Division and OAS Business Division Jun 2021 Appointed Representative Director, President (current)
1960-10-09
Takashi NAKAJIMA
Director and Vice President, in charge of Administration Division
Apr 1995 Joined the Company Jun 2007 Appointed Director, Togo Medikit Co., Ltd. Apr 2010 General Manager, Management Planning Office Jun 2010 Appointed Director Jun 2013 Appointed Representative Director, President, Togo Medikit Co., Ltd. (current) Jun 2013 In charge of Management Planning Jun 2019 Appointed Senior Managing Director Jun 2020 Appointed Senior Managing Director, in charge of Administration Division Jun 2021 Appointed Director and Vice President, in charge of Administration Division (current)
1970-02-14
Fumihiro NAKAJIMA
Director, in charge of Management Planning, Sales Administration Division, and Regulatory Affairs/Education
Apr 1987 Joined Asahi Mutual Life Insurance Company Dec 2002 Joined Tokio Marine and Fire Insurance Co., Ltd. (now Tokio Marine & Nichido Fire Insurance Co., Ltd.) Jul 2017 Joined the Company; Executive Officer, General Manager, Management Planning Office Jun 2019 Appointed Director, in charge of Management Planning Jun 2025 Appointed Director, in charge of Management Planning, Sales Administration Division, and Regulatory Affairs/Education (current)
1963-09-18
Yasuyuki YOSHIDA
Director
Apr 1971 Joined Asahi Chemical Industry Co., Ltd. (now Asahi Kasei Corporation) Apr 2010 Executive Officer, Asahi Kasei Corporation Apr 2011 Senior Executive Officer, Asahi Kasei Corporation Jun 2011 Director, Asahi Kasei Corporation Jun 2013 Advisor, Asahi Kasei Corporation Jun 2014 Advisor, Asahi Kasei Corporation (retired) Jun 2015 Appointed Director of the Company (current)
1948-02-14
Atsuko OTAKI
Director
Apr 1986 Joined Tohmatsu Touche Ross Consulting Co., Ltd. (now Abeam Consulting Ltd.) Apr 1994 Registered as Attorney-at-Law Apr 1994 Joined Ono Takao Law Office (now Ono Sogo Law Office) Jan 2004 Joined Ishimoto Tetsutoshi Law Office as Partner Attorney (current) Apr 2009 Specially Appointed Associate Professor, Graduate School of Law, Meiji University Apr 2012 Specially Appointed Professor, Graduate School of Law, Meiji University Feb 2016 Outside Director, JM Holdings Co., Ltd. (formerly Japan Meat Co., Ltd.) (current) Jun 2020 Outside Audit & Supervisory Board Member, Narasaki Sangyo Co., Ltd. Jun 2021 Appointed Director of the Company (current) Jun 2025 Outside Director (Audit and Supervisory Committee Member), Narasaki Sangyo Co., Ltd. (current)
1963-08-18
Toshiyuki IRIE
Director
Apr 1984 Medical Officer Candidate, Air Self-Defense Force Jul 1984 Resident, National Defense Medical College Hospital and Japan Self-Defense Forces Central Hospital Oct 1991 Resident Physician, Department of Radiology, Graduate School of Medicine (equivalent), National Defense Medical College Apr 1998 Lecturer, Department of Radiology, School of Medicine, University of Tsukuba Apr 2003 Chief Physician, Department of Radiology, Hitachi General Hospital, Hitachi, Ltd. Jun 2016 Professor, Department of Radiology, Mito Medical Education Center, University of Tsukuba Hospital Jun 2025 Appointed Director of the Company (current)
1960-02-17
Naomichi KANEKO
Full-time Audit & Supervisory Board Member
Aug 1981 Joined the Company Apr 2005 General Manager, Customer Service Department Apr 2015 General Manager, Indwelling Needle Marketing, Marketing Department Jun 2017 Appointed Audit & Supervisory Board Member (current)
1955-04-29
Shuji OSHIMA
Audit & Supervisory Board Member
Mar 1985 Registered as Certified Public Accountant Oct 1987 Opened Oshima Tax and Accounting Office (current) Nov 1987 Registered as Certified Tax Accountant Jun 2004 Audit & Supervisory Board Member, Nichii Gakkan Co., Ltd. Feb 2008 Audit & Supervisory Board Member, Kyowa Consultants Co., Ltd. Jun 2014 Appointed Audit & Supervisory Board Member of the Company (current) Feb 2016 Director, Kyowa Consultants Co., Ltd. (current)
1949-12-27
Fukuichi YOSHIDA
Audit & Supervisory Board Member
Aug 2015 Registered as Certified Tax Accountant Aug 2015 Opened Tax and Accounting Office (current) Jun 2021 Appointed Audit & Supervisory Board Member of the Company (current)
1954-11-28
Large Shareholding Reports
Valex Partners Co., Ltd.
2026-09-11
14.17%→14.53%
FMR Investment Management (UK) Limited
2026-07-23
5.78%
Fidelity Management & Research Company LLC
2026-06-10
4.89%→6.04%
FMR LLC
2026-06-10
—
Fidelity Management & Research Company LLC
2026-06-09
4.89%
FMR LLC
2026-06-09
—
Nakajima Corporation Co., Ltd.
2025-08-26
33.63%→37.09%
Annual report (as of 2026-03-31): 40.69%
VARECS Partners Limited
2025-03-07
12.70%→14.17%
VARECS Partners Limited
2024-03-06
11.61%→12.70%
VARECS Partners Limited
2024-01-11
5.00%→11.61%
Disclosures
No disclosures
Primary Source Filings
EDINET
2026-09-11
Large Shareholding Report
TDnet
2026-08-07
Q1 Earnings Flash
FY ending Mar 2027
EDINET
2026-07-23
Large Shareholding Report
EDINET
2026-06-24
Annual Securities Report
Period: Apr 2025 – Mar 2026
EDINET
2026-06-10
Large Shareholding Report
EDINETAmended
2026-06-10
Change Report
EDINETAmended
2026-06-09
Change Report
EDINET
2026-06-09
Large Shareholding Report
TDnet
2026-06-03
株主総会招集通知
TDnet
2026-02-12
Q3 Earnings Flash
FY ending Mar 2026
EDINET
2025-11-13
Semi-Annual Securities Report
Period: Apr 2025 – Mar 2026
EDINET
2025-08-26
Large Shareholding Report
TDnet
2025-08-08
Q1 Earnings Flash
FY ending Mar 2026
EDINET
2025-06-25
Annual Securities Report
Period: Apr 2024 – Mar 2025
EDINET
2025-03-07
Large Shareholding Report
TDnet
2025-02-10
Q3 Earnings Flash
FY ending Mar 2025
EDINET
2024-11-12
Semi-Annual Securities Report
Period: Apr 2024 – Mar 2025
TDnet
2024-08-09
Q1 Earnings Flash
FY ending Mar 2025
EDINET
2024-06-27
Annual Securities Report
Period: Apr 2023 – Mar 2024
EDINET
2024-03-06
Large Shareholding Report
EDINET
2024-02-13
Quarterly Securities Report
Period: Oct 2023 – Dec 2023
EDINET
2024-01-11
Large Shareholding Report
EDINET
2023-11-13
Quarterly Securities Report
Period: Jul 2023 – Sep 2023
EDINET
2023-08-14
Quarterly Securities Report
Period: Apr 2023 – Jun 2023
EDINET
2023-06-29
Annual Securities Report
Period: Apr 2022 – Mar 2023
EDINET
2023-02-13
Quarterly Securities Report
Period: Oct 2022 – Dec 2022
EDINET
2022-11-14
Quarterly Securities Report
EDINET
2022-08-12
Quarterly Securities Report
EDINET
2022-06-30
Annual Securities Report
EDINET
2022-02-14
Quarterly Securities Report
Ask AI
I have this company's financials, ownership, and management on hand. Ask me anything from an M&A perspective.
Ask me!
End of Preview

Try the full product

Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.

Free Demo (No Time Limit, 10 Companies) →